Concepedia

Yuichi Ando

YA

Statistics

Publications

15

Citations

444

H-Index

13

Active since

2011

Affiliations

Nagoya University Hospital(Current)

Nagoya University

Kobe University

National Cancer Center Hospital East

Kobe University Hospital

Yuichi Ando is an author at Nagoya University Hospital specializing in medicine, oncology, and cancer pharmacology.

ORCID

Publications per year

2011–2024

15

Publications

15

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

Antje Wick, Oliver Bähr, Martin Schüler et al. · Clinical Cancer Research · 2021 · 65 citations · Full text

, , +13

Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade

Yuki Miyai, Daisuke Sugiyama, Tetsunari Hase et al. · Life Science Alliance · 2022 · 50 citations · Full text

, , +17

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Yuichi Ando, Satoru Iwasa, Shunji Takahashi et al. · Cancer Science · 2018 · 48 citations · Full text

, , +17

Phase I dose-escalating study of panobinostat (LBH589) Administered intravenously to Japanese patients with advanced solid tumors

Sachi Morita, Satoshi Oizumi, Hironobu Minami et al. · Investigational New Drugs · 2011 · 42 citations

, , +9

Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies

Takanori Ito, Masatoshi Ishigami, Takafumi Yamamoto et al. · Hepatology International · 2021 · 38 citations

, , +17

1–5 of 15